• HyperScribe T7 High Yield Cy3 RNA Labeling Kit: Advanced Pro

  2026-06-25

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit delivers robust, tunable fluorescent RNA probe synthesis for demanding in situ hybridization and gene expression studies. Streamline complex workflows and achieve high reproducibility in RNA probe fluorescent detection with APExBIO’s optimized chemistry.

• Tetraethylammonium Chloride: Applied Workflows in Ion Channe

  2026-06-25

  Tetraethylammonium chloride (TEAC) from APExBIO empowers advanced potassium channel studies with dual-site pore blocking and high solubility for diverse assay formats. This guide details actionable workflows, protocol enhancements, and troubleshooting strategies to maximize reproducibility and interpretative power in vascular, neuronal, and metabolic models.

• Dasatinib Monohydrate (BMS-354825): Benchmarks in CML Resear

  2026-06-24

  Dasatinib Monohydrate (BMS-354825) is a potent, multitargeted tyrosine kinase inhibitor with robust efficacy against both nonmutated and imatinib-resistant BCR-ABL isoforms. This article synthesizes peer-reviewed evidence, molecular benchmarks, and workflow parameters for its application in chronic myeloid leukemia and Philadelphia chromosome-positive leukemias.

• Deferiprone in Enterocyte Metabolism: Protocols & Applicatio

  2026-06-23

  Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) is redefining iron modulation in cell models, enabling precise control over iron-dependent signaling and apoptosis assays. This article delivers workflow-ready guidance and troubleshooting strategies for researchers targeting cancer biology, oxidative stress, and intestinal health.

• Fosinopril Sodium: Bridging Pharmacokinetics and Translation

  2026-06-23

  Explore how Fosinopril sodium, a potent ACE inhibitor, uniquely bridges pharmacokinetic complexity with translational cardiovascular disease modeling. This article delivers deep scientific insights, practical assay parameters, and expert interpretation beyond conventional perspectives.

• L-Glutathione Reduced: Redox Innovation for Translational Im

  2026-06-22

  This article explores the centrality of L-Glutathione Reduced in decoding redox biology and advancing translational research, integrating mechanistic insights from glutamine metabolism, GOT1 inhibition, and cancer metabolism. It delivers protocol guidance, competitive context, and forward-looking translational strategies, highlighting how APExBIO’s reagent sets new standards for reliability and data integrity.

• Aztreonam: Monocyclic β-Lactam Antibiotic for Gram-Negative

  2026-06-22

  Aztreonam’s synthetic monocyclic β-lactam structure enables precise inhibition of Gram-negative aerobic bacteria and advanced resistance modeling. Leverage APExBIO’s Aztreonam for reproducible workflows, from cell wall synthesis assays to cytochrome P450 studies, with proven solubility and stability parameters for robust experimental design.

• Structural Insights into CD38 CAR Affinity Tuning and Select

  2026-06-21

  This study provides a detailed structural and functional analysis of two CD38-targeting CAR binders, uncovering how their distinct engagement modes and rational affinity tuning can minimize fratricide while maintaining antitumor efficacy. The findings inform the design of next-generation CAR-T therapies with optimized selectivity and safety profiles.

• Obeticholic Acid: Systems-Level Insights for Liver Fibrosis

  2026-06-20

  Discover how Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid) advances liver fibrosis research through FXR signaling, with a focus on systems-level gene modulation and immunometabolic interplay. Explore unique protocol strategies and comparative analysis not found in standard reviews.

• Protease Inhibitor Cocktail EDTA-Free: Neurodegeneration Res

  2026-06-19

  Explore how the Protease Inhibitor Cocktail EDTA-Free empowers neurodegeneration and phosphorylation studies by preserving protein integrity, with insights from recent neuroinflammation research. This article delivers scientific depth and unique assay guidance for advanced workflows.

• Azithromycin and Roxithromycin: Macrolide Antibiotics as Hum

  2026-06-19

  Ozsvari et al. (2018) identified azithromycin and roxithromycin as the first clinically approved antibiotics with selective senolytic activity against human fibroblasts. Their work demonstrates a streamlined assay to repurpose existing drugs for aging research, providing a foundation for translational studies in senescence-targeted therapy.

• Nicotine Signaling and CKD Progression: Mechanistic Insights

  2026-06-18

  This article reviews the pivotal findings of Jain and Jaimes, who elucidate the mechanistic role of nicotine in chronic kidney disease (CKD) progression among smokers. The study highlights the contribution of nicotine-induced oxidative stress and non-neuronal nAChR activation to renal injury, opening new avenues for research targeting these pathways.

• Lactate Drives HMGB1 Modification and Exosomal Release in Se

  2026-06-18

  This study uncovers how elevated lactate levels in polymicrobial sepsis promote both lactylation and acetylation of HMGB1 in macrophages, facilitating its exosomal release. The findings reveal a mechanistic link between metabolic disturbance and inflammatory signaling, suggesting new strategies for sepsis intervention.

• Tomivosertib: Selective MNK1 Inhibitor for MNK-eIF4E Pathway

  2026-06-17

  Tomivosertib is a potent, selective MNK1/2 inhibitor that blocks eIF4E phosphorylation and modulates oncogenic signaling. It offers high specificity in cell-based and in vivo studies targeting the MNK-eIF4E and related metabolic pathways. Recent research supports its application in acute myeloid leukemia and models requiring precise translational control.

• CCT007093: Advancing Precision in PPM1D-P38 Pathway Research

  2026-06-17

  Explore the strategic and mechanistic value of CCT007093, a selective PPM1D inhibitor, for translational researchers seeking to dissect p38 MAPK-driven mechanisms in cancer and kidney injury. Integrating new evidence, workflow strategies, and protocol guidance, this article guides impactful experimental design and highlights how CCT007093 from APExBIO stands apart from standard reagents.

460 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page